Pat Cotroneo

Chief Financial Officer & Chief Accounting Officer at FibroGen, Inc.

Pat Cotroneo

Pat Cotroneo

Chief Financial Officer & Chief Accounting Officer at FibroGen, Inc.

Biography

Presently, Pat Cotroneo occupies the position of Chief Financial Officer & Senior VP-Finance at FibroGen, Inc. In the past he occupied the position of Controller at Genetic Therapy, Inc. and Controller of Systemix, Inc. He received an undergraduate degree from the University of San Francisco.

Overview
Career Highlights

FibroGen, Inc.

RelSci Relationships

643

Birthday

1964

Age

57

Relationships
RelSci Relationships are individuals Pat Cotroneo likely has professional access to. A relationship does not necessarily indicate a personal connection.

Interim President at FibroGen, Inc.

Relationship likelihood: Strong

Chief Executive Officer at FibroGen, Inc.

Relationship likelihood: Strong

Counsel at Goodwin Procter LLP

Relationship likelihood: Strong

Chief Intellectual Property Officer at FibroGen, Inc.

Relationship likelihood: Strong

Chief Legal Officer at FibroGen, Inc.

Relationship likelihood: Strong

Executive Director, Clinical Development at FibroGen, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Executive Director at AVITA Medical, Inc.

Relationship likelihood: Strong

Chief Business Officer at FibroGen, Inc.

Relationship likelihood: Strong

Chief Medical Officer at FibroGen, Inc.

Relationship likelihood: Strong

Executive Director at FibroGen, Inc.

Relationship likelihood: Strong

Paths to Pat Cotroneo
Potential Connections via
Relationship Science
You
Pat Cotroneo
Chief Financial Officer & Chief Accounting Officer at FibroGen, Inc.
Education

Our mission is to promote learning in the Jesuit Catholic tradition. The university offers undergraduate, graduate and professional students the knowledge and skills needed to succeed, and the values and sensitivity necessary to be men and women for others.

Career History
Chief Financial Officer & Chief Accounting Officer
2000 - Current

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Controller
1993 - 2000

Part of Novartis AG, Systemix, Inc. is an American company located in Palo Alto, CA, that develops cell-based gene therapies for diseases. It was founded by Irving L. Weissman and Leroy E. Hood. Linda D. Sonntag is currently the CEO of the firm. Novartis AG acquired Systemix, Inc. on 14 Feb 97 for $75.90 million.

Controller
1993 - 2000

Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD.

Political Donations
$3,000
2012

Former President of United States

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Pat Cotroneo is affiliated with FibroGen, Inc., Systemix, Inc., Genetic Therapy, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pat Cotroneo. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pat Cotroneo's profile does not indicate a business or promotional relationship of any kind between RelSci and Pat Cotroneo.